MedTrace Logo

OcuDyne System in the Treatment of AMD

NCT05091476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2025-02-13

No results posted yet for this study

Summary

Feasibility of the OcuDyne OPTiC System in patients with late-stage non-exudative age-related macular degeneration.

Conditions

  • Age-Related Macular Degeneration

Interventions

DEVICE

OPTiC System

OPTiC System procedure

Sponsors & Collaborators

  • OcuDyne, Inc.

    lead INDUSTRY

Principal Investigators

  • Luana R Wilbur, BS · OcuDyne VP, Clinical and Regulatory Affairs

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2024-07-31
Completion
2024-10-01

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05091476 on ClinicalTrials.gov